Form 4: OneMedNet Director Jair Clarke Boosts Stake with RSU Grants

OneMedNet Corp Director Jair Clarke reported the acquisition of 138,485 common stock shares through restricted stock unit grants for board and committee service.

Summary

• Jair Clarke, a Director of OneMedNet Corp (ONMD), reported the acquisition of 138,485 shares of common stock through Restricted Stock Units (RSUs).
• On October 1, 2024, 11,342 RSUs were granted for 2024 board service, vesting on December 31, 2024.
• On January 1, 2025, 82,143 RSUs were granted for Commercial Committee service, with 50% vesting quarterly based on continued service and the remaining 50% vesting if the issuer's revenue exceeds a specific threshold determined by the Board of Directors.
• On November 26, 2025, 45,000 RSUs were granted for 2025 board service, vesting on December 31, 2025.
• All RSUs were granted at a price of $0.00 per share under the OneMedNet Corporation 2022 Equity Incentive Plan.

Sentiment

Score: 7

Explanation: The acquisition of restricted stock units by a director, including performance-based vesting, generally indicates alignment of interests and confidence in future performance, although these are compensation grants rather than open market purchases.

Positives

• Increased beneficial ownership by a director, aligning management interests with shareholder value.
• A portion of the RSU grants (50% of 82,143 units) is performance-based, tied to the achievement of a specific revenue threshold, incentivizing growth.

Negatives

• The RSUs were granted at a $0.00 price, indicating compensation rather than an open market purchase, which would typically signal stronger conviction.

Risks

• The vesting of 50% of the 82,143 RSUs is contingent on the issuer's revenue exceeding a specific threshold, introducing a performance risk for the full realization of these units.

Future Outlook

The performance-based vesting condition for a significant portion of the RSUs indicates a forward-looking focus on achieving specific revenue growth targets set by the Board of Directors.

Industry Context

The granting of restricted stock units as compensation for board and committee service is a standard practice in publicly traded companies across various industries, aligning director incentives with company performance and shareholder interests.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) as director compensation is a common practice, comparable to equity compensation structures seen in many public companies.
• The inclusion of performance-based vesting conditions, such as a revenue threshold for a portion of the RSUs, aligns with best practices for incentivizing management and directors to achieve strategic financial goals, similar to performance share units (PSUs) used by peers.

Corporate Governance

Related Party Transactions

• The RSU grants to Director Jair Clarke constitute related party transactions, which are standard compensation practices for board service.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of director interests with company performance, especially with performance-based vesting.
• Employees (Directors): Direct impact through equity compensation for services rendered.

Next Steps

• Continued service of Jair Clarke with the issuer through the specified vesting dates.
• Achievement of the specific revenue threshold determined by the Board of Directors for the performance-based RSUs.

Key Dates

Recommendation

This Form 4 filing details routine director compensation through restricted stock unit grants, which is an expected part of corporate governance and does not provide new information warranting a change in investment recommendation. While the increased insider ownership is a positive for alignment, it's not an open market purchase and doesn't signal a significant new catalyst for the stock price.

Keywords

OneMedNet Corp, ONMD, Jair Clarke, Form 4, SEC filing, Restricted Stock Units, RSUs, Director Compensation, Equity Incentive Plan, Insider Ownership